Literature DB >> 15595985

Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia. 1983.

L Lennard, C A Rees, J S Lilleyman, J L Maddocks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15595985      PMCID： PMC1884668          DOI： 10.1111/j.1365-2125.2004.02314.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Research priorities in biomarkers and surrogate end-points.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

2.  Personalized drug therapy; the genome, the chip and the physician.

Authors:  Lionel D Lewis
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

3.  Monitoring for harms of therapy.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-04       Impact factor: 4.335

4.  Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes.

Authors:  Alice Matimba; Fang Li; Alina Livshits; Cher S Cartwright; Stephen Scully; Brooke L Fridley; Gregory Jenkins; Anthony Batzler; Liewei Wang; Richard Weinshilboum; Lynne Lennard
Journal:  Pharmacogenomics       Date:  2014-03       Impact factor: 2.533

5.  The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease.

Authors:  Marius Vögelin; Luc Biedermann; Pascal Frei; Stephan R Vavricka; Sylvie Scharl; Jonas Zeitz; Michael C Sulz; Michael Fried; Gerhard Rogler; Michael Scharl
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.